Hsia-lien Lin
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
Papers in
- Pharmacology 22
- Pharmacogenetics and Drug Metabolism 22
- Inflammatory mediators and NSAID effects 3
- Oncology 12
- Drug Transport and Resistance Mechanisms 11
- Co-authors
- Paul F. Hollenberg (25 shared papers)Ute M. Kent (6 shared papers)Haoming Zhang (9 shared papers)Lucy Waskell (4 shared papers)Yoichi Osawa (2 shared papers)Jan R. Crowley (1 shared paper)Elizabeth S. Roberts (1 shared paper)Haoming Zhang (4 shared papers)
- Journals
- Journal of Pharmacology and Experimental Therapeutics (8 papers)Chemical Research in Toxicology (7 papers)Drug Metabolism and Disposition (5 papers)Biochemistry (2 papers)Molecular Pharmacology (1 paper)
- Partner nations
- United StatesAustraliaItaly
In The Last Decade
Hsia-lien Lin
26 papers receiving 783 citations
Peers
Comparison fields: 5 of 91
- Pharmacology 467
- Biochemistry 114
- Oncology 217
- Computational Theory and Mathematics 107
- Physiology 101
Countries citing papers authored by Hsia-lien Lin
This map shows the geographic impact of Hsia-lien Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsia-lien Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsia-lien Lin more than expected).
Fields of papers citing papers by Hsia-lien Lin
This network shows the impact of papers produced by Hsia-lien Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsia-lien Lin. The network helps show where Hsia-lien Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Hsia-lien Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 106 | |
| 2 | 1998 | 88 | |
| 3 | 2005 | 72 | |
| 4 | 2001 | 46 | |
| 5 | 1999 | 43 | |
| 6 | 2003 | 41 | |
| 7 | 2005 | 38 | |
| 8 | 2011 | 34 | |
| 9 | 2007 | 34 | |
| 10 | 2006 | 29 | |
| 11 | 2010 | 27 | |
| 12 | 2006 | 25 | |
| 13 | 2007 | 24 | |
| 14 | 2009 | 23 | |
| 15 | 2010 | 19 | |
| 16 | 2012 | 19 | |
| 17 | 2013 | 18 | |
| 18 | 2009 | 16 | |
| 19 | 2010 | 16 | |
| 20 | 2005 | 16 |
About Hsia-lien Lin
Hsia-lien Lin is a scholar working on Pharmacology, Oncology, Molecular Biology, Pharmacology and Computational Theory and Mathematics, having authored 26 papers that have together received 799 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (22 papers), Drug Transport and Resistance Mechanisms (11 papers), Receptor Mechanisms and Signaling (4 papers), Computational Drug Discovery Methods (3 papers), Inflammatory mediators and NSAID effects (3 papers), Alcohol Consumption and Health Effects (2 papers), Epigenetics and DNA Methylation (2 papers) and Eicosanoids and Hypertension Pharmacology (2 papers). The work is most often cited by research in Pharmacology (467 citations), Biochemistry (114 citations), Oncology (217 citations), Computational Theory and Mathematics (107 citations) and Physiology (101 citations). Hsia-lien Lin has collaborated with scholars based in United States, Australia and Italy. Frequent co-authors include Paul F. Hollenberg, Ute M. Kent, Haoming Zhang, Lucy Waskell, Yoichi Osawa, Jan R. Crowley, Elizabeth S. Roberts, Haoming Zhang, Jonathan Maybaum and Leslie A. Parsels. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Chemical Research in Toxicology, Drug Metabolism and Disposition, Biochemistry and Molecular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.